Open Menu

Insight & Resources

Webinar

Leveraging a “Reverse Engineering Methodology” in Drug Development for On-time Delivery during COVID-19

Leveraging a “Reverse Engineering Methodology” in Drug Development for On-time Delivery during COVID-19

In these extraordinary times, CDMO’s find themselves in the unique territory, helping to supply innovators with clinical trial materials intended for COVID-19 applications as well as managing tremendous pressure in delivering products with raw material and supply chain scarcity. Often, timing requirements for these urgent projects pose significant challenges to typical CDMO timelines.  However, when forced to find a solution, there are some options available to CDMO managers that can bridge this potentially cavernous gap.

At Cambrex we follow a “Reverse Engineering Methodology” helping our customers during these challenging times to ensure that timely deliveries are secured as well as supply chain efficiency is safeguarded.

Our on-demand webinar will showcase valuable case studies and new methodologies that can help the wider CDMO industry in tackling delays in project deliveries. We also cover our strategy to ensure the delivery of drugs to customers and patients in lieu of the COVID-19 outbreak with additional issues such as raw material and re-homing issues.

Speakers

Ralph Landau, Head of Development at Cambrex

Ralph Landau, Head of Development at Cambrex

Satish Shetty, Director of Product Development at Cambrex

Satish Shetty, Director of Product Development at Cambrex